The Southern African Journal of Gynaecological Oncology (SAJGO) is the official journal of the South African Society of Gynaecologic Oncology (SASGO) and the South African Society of Clinical and Radiation Oncology (SASCRO).

The Journal aims to be the prime journal on women’s cancer for local healthcare workers and gynaecologists, focusing on all aspects of cancer prevention, detection, diagnosis and treatment. The SAJGO is also a specialist journal catering for sub-specialist gynaecologic oncologists, for other specialists with a specific interest in breast and gynaecologic cancer, including medical oncologists, radiation oncologists, surgeons, radiologists, pathologists, geneticists, specialised nurses and research scientists.

The Journal supports the vision of SASGO, namely to promote excellence in gynaecologic cancer care and will also aim to promote excellence in breast cancer care. The Journal also supports the mission of the society and will assist SASGO with all aspects of communication, training, advocacy and by supporting and stimulating local research.

The Science is in the Sample – provided it is Representative

Current sampling practice is a result of the combination of statistics with scientific knowledge about the product/material being sampled.  Such knowledge is acquired through experimentation and the use of various sampling techniques until reproducible results, from representative samples, can be obtained. 

NEW LEADERSHIP AT THE HELM OF GENERICS AND BIOSIMILAR MEDICINES ASSOCIATION

Generic and Biosimilar Medicines of Southern Africa (GBMSA), formerly known as the National Association of Pharmaceutical Manufacturers (NAPM), has appointed Erik Roos, CEO of Pharma Dynamics as Vice Chairperson to support the existing Chairperson, Lorraine Keyser, CEO of Dr Reddy’s, as of June 2018.

One year on – Novartis, DST and SAMRC MoU builds scientific capability in South Africa

One year after the signing of a Memorandum of Understanding (MoU) between Novartis, the South African Department of Science and Technology (DST) and South African Medical Research Council (SAMRC), Novartis reports that the collaboration is revealing significant latent potential for scientific discovery in South Africa.

The SpineCor Scoliosis Brace – A first of its kind in South Africa

MER Healthcare Consulting has introduced the new Scoliosis SpineCor Brace to the South African market. SpineCor is 3 dimensional dynamic brace used to help prevent progression of a curve in Idiopathic Scoliosis for adolescents and degenerative painful scoliosis in adults.

INOVA LAUNCHES A NEW ANTI-INFLAMMATORY GEL

iNova Pharmaceuticals is proud to launch a new anti-inflammatory gel, to add to South Africa’s most prescribed muscle relaxant brand, Norflex.

SAJGO (July 2016 – June 2017) | 1 142